Salvage of relapsed malignant histiocytosis by autologous bone marrow transplant
Berry, J.; Russell, J.A.
Bone Marrow Transplantation 4(1): 123-124
1989
ISSN/ISBN: 0268-3369 PMID: 2466511 Document Number: 335342
A 21-year-old female presenting with malignant histiocytosis was initially treated with conventional aggressive chemotherapy resulting in complete remission (CR) but relapsed within 6 months of discontinuation. The patient was reinduced with two cycles of cis-platinum, cytosine arabinoside and mitoxantrone and achieved CR, at which time she received single agent high-dose melphalan followed by autologous bone marrow transplant. She remains in CR 36 months after the autograft procedure.
Document emailed within 1 workday
Related Documents
Cazin, B.; Gorin, N.C.; Jouet, J.P.; Laporte, J.P.; Fenaux, P.; Walter, M.P.; Najman, A.; Gosselin, B.; Bauters, F. 1990: Successful autologous bone marrow transplantation in second remission of malignant histiocytosis Bone Marrow Transplantation 5(6): 431-433Cooper, M.H.; Maraninchi, D.; Gastaut, J.A.; Mannoni, P.; Carcassonne, Y. 1993: HIV infection in autologous and allogeneic bone marrow transplant patients: a retrospective analysis of the Marseille bone marrow transplant population Journal of Acquired Immune Deficiency Syndromes 6(3): 277-284
Kessinger, A.; Vose, J.M.; Bierman, P.J.; Armitage, J.O. 1991: High-dose therapy and autologous peripheral stem cell transplantation for patients with bone marrow metastases and relapsed lymphoma: an alternative to bone marrow purging Experimental Hematology 19(10): 1013-1016
Rowlings, P.A.; Horowitz, M.M.; Armitage, J.O.; Gale, R.P.; Sobocinski, K.A.; Zhang, M.J.; Bortin, M.M. 1993: Report from the International Bone Marrow Transplant Registry and the North American Autologous Bone Marrow Transplant Registry Clinical transplants 1993: 101-108
Ueda, M.; Joshi, I.D.; Dan, M.; Uberti, J.P.; Chou, T.H.; Sensenbrenner, L.L.; Lum, L.G. 1993: Preclinical studies for adoptive immunotherapy in bone marrow transplantation. Generation of anti-CD3 activated cytotoxic T cells from normal donors and autologous bone marrow transplant candidates Transplantation 56(2): 351-356
Crump, M.; Brandwein, J.M.; Smith, A.M.; Langley, G.R.; Burnell, M.J.; Huebsch, L.B.; Markman, S.J.; Robinson, K.S.; Sutton, D.M.; Solh, H. 1992: A regional autologous bone marrow transplant network: transfers to designated centers on the day after transplant Bone Marrow Transplantation 9(6): 445-450
Lu, D.; Liu, D.; Liu, K. 1998: Report from the Chinese Bone Marrow Transplant Registry with special regard to autologous transplant Chinese Medical Journal 111(8): 675-677
Schrøder, H.; Clausen, N.; Thorling, K.; Hokland, P. 1993: Autologous bone marrow transplantation in children with malignant diseases. Bone marrow harvest and procedure-related toxicity Ugeskrift for Laeger 155(20): 1536-1539
Vowels, M.R.; White, L.; Lam-Po-Tang, P.R. 1987: Bone marrow transplantation for malignant histiocytosis Bone Marrow Transplantation 2(1): 110
Fegan, C.; Thomas, H.; Bailey-Wood, R.; Coleman, S.; Phillips, S.; Hoy, T.; Whittaker, J.A. 1995: In vitro LAK (lymphokine activated killer) activity following autologous peripheral blood stem cell is significantly greater than that following autologous bone marrow and allogeneic bone marrow transplantation Bone Marrow Transplantation 16(2): 277-281
Stemmelin, G.R.; Pest, P.; Peters, R.A.; Ceresetto, J.M.; Shanley, C.M.; Bullorsky, E.O. 1995: Severe esophageal stricture after autologous bone marrow transplant Bone Marrow Transplantation 15(6): 1001-1002
Biggs, D.; Stadtmauer, E.; Mangan, P.; Edelstein, M.; Powlis, W.; Buzby, G.; Magee, D.; Sachs, B.; Silberstein, L. 1994: 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery Progress in Clinical and Biological Research 389: 9-15
Ozsahin, H.; Fabrega, S.; Douay, L.; Barbu, V.; Gorin, N.C. 1990: Application of serum-free liquid bone marrow cultures to bone marrow purging for autologous bone marrow transplantation in acute lymphoblastic leukemia Nouvelle Revue Francaise d'Hematologie 32(5): 353-355
Philip, T. 1991: The role of high dose therapy and autologous bone marrow transplant in children with malignancies Bone Marrow Transplantation 7(Suppl 3): 104-105
Schmid, H.; Henze, G.; Schwerdtfeger, R.; Baumgarten, E.; Besserer, A.; Scheffler, A.; Serke, S.; Zingsem, J.; Siegert, W. 1993: Fractionated total body irradiation and high-dose VP-16 with purged autologous bone marrow rescue for children with high risk relapsed acute lymphoblastic leukemia Bone Marrow Transplantation 12(6): 597-602
Johnsen, H.E.; Birgens, H.; Hansen, N.E. 1991: Autologous bone marrow transplantation in malignant hematologic diseases Ugeskrift for Laeger 153(25): 1790-1793
Brice, P.; Pautier, P.; Marolleau, J.P.; Castaigne, S.; Gisselbrecht, C. 1994: Pregnancy after autologous bone marrow transplantation for malignant lymphomas Nouvelle Revue Francaise d'Hematologie 36(5): 387-388
Domingo-Albós, A.; García, J.; Puig, J.; Brunet, S.; Ayats, R.; Pardo, N.; Soler, J.; Muñiz, E.; Badell, I. 1990: Treatment of resistant or relapsing Hodgkin's disease with high doses of chemotherapy followed by autologous bone marrow transplant Medicina Clinica 94(9): 321-324
Esteban, J.M.; Somlo, G. 1995: Skin biopsy in allogeneic and autologous bone marrow transplant patients: a histologic and immunohistochemical study and review of the literature Modern Pathology: An Official Journal of the United States and Canadian Academy of Pathology Inc 8(1): 59-64
Christiansen, N.P.; Haake, R.J.; Hurd, D.D. 1991: Early herpes zoster infection in adult patients with Hodgkin's disease undergoing autologous bone marrow transplant Bone Marrow Transplantation 7(6): 435-437